Clinically, this heterogeneous disease is classified into three main types based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status: hormone receptor (HR)-positive, HER2-positive, and triple-negative breast cancers (TNBC) [1]. Here, PGR is linked to triple-negative breast carcinoma.